http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2576834-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f48cc888734096f4e34dcc05a8df99f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e17a9fe8ae81a09478a814ec5ef3177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d394bb6a7044b4c7d2400ddb8a56152
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69f6d91ee2804fc6366e2e906f955827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12cf4ee647332a56313949fa2b6b0ae1
publicationDate 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2576834-C2
titleOfInvention Method of treating eczema
abstract FIELD: medicine. n SUBSTANCE: invention concerns a method of treating eczema, characterised by the fact that a routine therapeutic approach is added by coating the involved skin area with 0.1% tacrolimus for 1 month in the morning and evening, and then for 2 months, once before bedtime; when using tacrolimus, applying any other agents on the skin area coated with tacrolimus and taking water procedures shall be avoided. n EFFECT: invention enables reducing or eliminating the risk of side effects and tachyphylaxis, and prolonging the remission. n 2 ex
priorityDate 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2414224-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2329037-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011104205-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2396982-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451114410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32624
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589645
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14225
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8674098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447582325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581125
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441335
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6509979
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID379069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426116329

Total number of triples: 52.